{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:31:25Z","timestamp":1790238685804,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.lpm.2016.10.011","type":"journal-article","created":{"date-parts":[[2016,11,5]],"date-time":"2016-11-05T03:00:34Z","timestamp":1478314834000},"page":"e369-e375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"P1","title":["Diminution de la pr\u00e9valence du docteur shopping de la bupr\u00e9norphine entre 2004\u00a0et 2014\u00a0en France"],"prefix":"10.1016","volume":"45","author":[{"given":"M\u00e9lanie","family":"Kernisant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Delorme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Kabore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Brousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Laporte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Zenut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chouki","family":"Chenaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Authier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. A","key":"10.1016\/j.lpm.2016.10.011_bib0180","first-page":"A27","article-title":"Suivi de patients pharmacod\u00e9pendants aux opiac\u00e9s trait\u00e9s par bupr\u00e9norphine haut dosage \u00e0 partir des r\u00e9seaux de soins","volume":"151","author":"De Ducla","year":"2000","journal-title":"Ann Med Interne"},{"key":"10.1016\/j.lpm.2016.10.011_bib0185","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1111\/j.1360-0443.2005.01271.x","article-title":"Harm reduction interventions, behaviours and associated health outcomes in France, 1996\u20132003","volume":"100","author":"Emmanuelli","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.lpm.2016.10.011_bib0190","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1111\/j.1360-0443.2007.02025.x","article-title":"Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study","volume":"102","author":"Davoli","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.lpm.2016.10.011_bib0195","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.lpm.2016.10.011_bib0200","series-title":"Mortality related to drug use in Europe: Public Health Implications","author":"EMCDDA","year":"2011"},{"key":"10.1016\/j.lpm.2016.10.011_bib0205","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/IJGM.S61014","article-title":"The current status of opioid maintenance treatment in France: a survey of physicians, patients, and out-of-treatment opioid users","volume":"7","author":"Benyamina","year":"2014","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.lpm.2016.10.011_bib0210","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/pds.2263","article-title":"Misuse of buprenorphine maintenance treatment since introduction of its generic forms: OPPIDUM survey: misuse of buprenorphine","volume":"21","author":"Nordmann","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.lpm.2016.10.011_bib0215","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.drugpo.2015.03.007","article-title":"Diversion of opioid maintenance treatment medications and predictors for diversion among Finnish maintenance treatment patients","volume":"26","author":"Launonen","year":"2015","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.lpm.2016.10.011_bib0220","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.drugpo.2010.10.004","article-title":"The prevalence and correlates of buprenorphine inhalation amongst opioid substitution treatment (OST) clients in Australia","volume":"22","author":"Horyniak","year":"2011","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.lpm.2016.10.011_bib0225","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1111\/j.1360-0443.2010.03092.x","article-title":"The global diversion of pharmaceutical drugs non-medical use and diversion of psychotropic prescription drugs in North America: a review of sourcing routes and control measures","volume":"105","author":"Fischer","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.lpm.2016.10.011_bib0230","first-page":"42","article-title":"Doctor shopping: a phenomenon of many themes","volume":"9","author":"Sansone","year":"2012","journal-title":"Innov Clin Neurosci"},{"key":"10.1016\/j.lpm.2016.10.011_bib0235","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.revmed.2014.11.009","article-title":"French health insurance databases: what interest for medical research?","volume":"36","author":"Moulis","year":"2015","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.lpm.2016.10.011_bib0240","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jpain.2012.10.012","article-title":"Comparison of opioid doctor shopping for tapentadol and oxycodone: a cohort study","volume":"14","author":"Cepeda","year":"2013","journal-title":"J Pain"},{"key":"10.1016\/j.lpm.2016.10.011_bib0245","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/0091270012436561","article-title":"Opioid shopping behavior: how often, how soon, which drugs, and what payment method","volume":"53","author":"Cepeda","year":"2013","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.lpm.2016.10.011_bib0250","series-title":"Conf\u00e9rence de consensus. Strat\u00e9gies th\u00e9rapeutiques pour les personnes d\u00e9pendantes des opiac\u00e9s\u00a0: place des traitements de substitution","author":"F\u00e9d\u00e9ration fran\u00e7aise d\u2019addictologie (FFA)","year":"2004"},{"key":"10.1016\/j.lpm.2016.10.011_bib0255","series-title":"Initiation au suivi du traitement substitutif de la pharmacod\u00e9pendance majeure aux opiac\u00e9s par bupr\u00e9norphine haut dosage","author":"Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (AFSSAPS)","year":"2011"},{"key":"10.1016\/j.lpm.2016.10.011_bib0260","series-title":"Avis de la commission de transparence concernant le chlorhydrate de m\u00e9thadone","author":"Haute Autorit\u00e9 de sant\u00e9","year":"2012"},{"key":"10.1016\/j.lpm.2016.10.011_bib0265","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drugalcdep.2012.03.009","article-title":"Estimated magnitude of diversion and abuse of opioids relative to benzodiazepines in France","volume":"126","author":"Pauly","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.lpm.2016.10.011_bib0270","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.drugpo.2007.03.002","article-title":"Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia","volume":"19","author":"Winstock","year":"2008","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.lpm.2016.10.011_bib0275","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3109\/10826080903080664","article-title":"Diversion and injection of methadone and buprenorphine among clients in public opioid treatment clinics in New South Wales, Australia","volume":"45","author":"Winstock","year":"2010","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.lpm.2016.10.011_bib0280","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/02791072.2014.960109","article-title":"Diversion of methadone and buprenorphine from opioid substitution treatment: a staff perspective","volume":"46","author":"Johnson","year":"2014","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.lpm.2016.10.011_bib0285","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1526-4637.2009.00603.x","article-title":"Prescription opioid abuse and diversion in an urban community: the results of an ultrarapid assessment","volume":"10","author":"Inciardi","year":"2009","journal-title":"Pain Med"},{"key":"10.1016\/j.lpm.2016.10.011_bib0290","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.drugalcdep.2014.06.005","article-title":"Factors contributing to the rise of buprenorphine misuse: 2008\u20132013","volume":"142","author":"Cicero","year":"2014","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.lpm.2016.10.011_bib0295","first-page":"23","article-title":"Quality of care provided to patients receiving opioid maintenance treatment in Europe: results from the EQUATOR analysis","volume":"14","author":"Dale-Perera","year":"2012","journal-title":"Heroin Addict Relat Clin Probl"},{"key":"10.1016\/j.lpm.2016.10.011_bib0300","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1472-8206.2011.00950.x","article-title":"Which psychoactive prescription drugs are illegally obtained and through which ways of acquisition? About OPPIDUM survey","volume":"26","author":"Frauger","year":"2012","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.lpm.2016.10.011_bib0305","series-title":"Donn\u00e9es r\u00e9centes relatives aux traitements de substitution aux opiac\u00e9s","author":"Observatoire fran\u00e7ais des drogues et des toxicomanies (OFDT)","year":"2013"},{"key":"10.1016\/j.lpm.2016.10.011_bib0310","series-title":"Tableau de bord annuel des traitements de substitution aux opiac\u00e9s","author":"Observatoire fran\u00e7ais des drogues et des toxicomanes (OFDT)","year":"2015"},{"key":"10.1016\/j.lpm.2016.10.011_bib0315","article-title":"Comparison of the risks of shopping behavior and opioid abuse between tapentadol and oxycodone and association of shopping behavior and opioid abuse","author":"Cepeda","year":"2013","journal-title":"Clin J Pain"},{"key":"10.1016\/j.lpm.2016.10.011_bib0320","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jpsychores.2012.02.009","article-title":"Dynamic risk factors in the misuse of opioid analgesics","volume":"72","author":"Pergolizzi","year":"2012","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.lpm.2016.10.011_bib0325","doi-asserted-by":"crossref","first-page":"e69241","DOI":"10.1371\/journal.pone.0069241","article-title":"Estimating the prevalence of opioid diversion by \u201cdoctor shoppers\u201d in the United States","volume":"8","author":"McDonald","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.lpm.2016.10.011_bib0330","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/11596600-000000000-00000","article-title":"Assessing opioid shopping behaviour: a large cohort study from a medication dispensing database in the US","volume":"35","author":"Cepeda","year":"2012","journal-title":"Drug Saf"},{"key":"10.1016\/j.lpm.2016.10.011_bib0335","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jsat.2008.02.001","article-title":"Prescription Opioid Misuse Index: a brief questionnaire to assess misuse","volume":"35","author":"Knisely","year":"2008","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.lpm.2016.10.011_bib0340","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/pds.1717","article-title":"Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study","volume":"18","author":"Noize","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.lpm.2016.10.011_bib0345","doi-asserted-by":"crossref","first-page":"f5599","DOI":"10.1136\/bmj.f5599","article-title":"Friends, doctors, and tramadol: we might have a problem","volume":"347","author":"Winstock","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.lpm.2016.10.011_bib0175","doi-asserted-by":"crossref","first-page":"ES9","DOI":"10.36076\/ppj.2012\/15\/ES9","article-title":"Opioid epidemic in the United States","volume":"15","author":"Manchikanti","year":"2012","journal-title":"Pain Physician"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498216303177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498216303177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T15:26:22Z","timestamp":1657639582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498216303177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0755498216303177"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2016.10.011","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diminution de la pr\u00e9valence du docteur shopping de la bupr\u00e9norphine entre 2004\u00a0et 2014\u00a0en France","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2016.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}